FDA OKs First Drug for Liver Disease-Related Pruritus
(MedPage Today) -- The FDA approved linerixibat (Lynavoy) as the first drug indicated for cholestatic pruritus stemming from primary biliary ...
(MedPage Today) -- The FDA approved linerixibat (Lynavoy) as the first drug indicated for cholestatic pruritus stemming from primary biliary ...
(MedPage Today) -- People with a genetic risk for Alzheimer's disease did not have an expected increase in cognitive decline ...
(MedPage Today) -- In this video, Mikhail Varshavski, DO, who goes by "Dr. Mike," talks with Trisha Pasricha, MD, about ...
(MedPage Today) -- Artificial intelligence (AI) could potentially be used to safely exclude low-risk mammograms from radiologist review, according to ...
(MedPage Today) -- Some physician practices are charging patients for prior authorization requests or requiring annual administrative fees for such ...
Ontario is planning to create a provincewide electronic medical record system for primary care, more than two decades after the ...
(MedPage Today) -- The FDA approved a higher dose of the GLP-1 receptor agonist semaglutide for weight loss, dubbed Wegovy ...
(MedPage Today) -- Groups representing medical practices are expressing concerns about a proposed rule from the Trump administration that would ...
(MedPage Today) -- A non-ablative treatment for benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS) achieved durable improvement in urinary ...
(MedPage Today) -- A case report review examined complications, diagnosis, and treatment of genital Crohn's disease, a rare extraintestinal manifestation ...
© 2025 PickByDoc. All rights reserved. PickByDoc is a medical news & health awareness platform.